Skip to main content

Rheumatoid arthritis

Epidemiology

Rituximab and rheumatology practice in the COVID-19 era

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

27-01-2022 | Diagnosis and screening | News

Joint pain plus antibody positivity may indicate need for rheumatology referral

Classifying individuals with musculoskeletal symptoms and no clinical synovitis using anti-cyclic citrullinated peptide antibody levels and self-reported hand or foot pain may be useful to prioritize rheumatology referrals, study findings indicate.

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of SLE

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

New additions to the Adis Journal Club

Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

ACR Convergence 2021

3–9 November: Keep up with the latest news and interviews from the conference.

Febuxostat and cardiovascular risk in people with gout

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

19-03-2021 | Rheumatoid arthritis | News

Excess myocardial infarction risk remains high in people with RA

People with rheumatoid arthritis still have a substantial excess risk for acute myocardial infarction relative to the general population even though rates have fallen in both groups in recent years, Canadian research shows.

Telemedicine in rheumatology

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Get ready for ACR Convergence 2020

ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

02-03-2020 | Rheumatoid arthritis | News

Serologic RA profile may be changing with time

The overall incidence of rheumatoid arthritis during 2005–2014 was similar that of earlier decades, but the rates of RF-negative disease have increased substantially with time, US study data show.

Global RA burden ‘significant, yet under-recognized’

Global RA burden ‘significant, yet under-recognized’

Almost 20 million people worldwide were living with rheumatoid arthritis in 2017, with over a million new cases diagnosed each year, according to estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study.

Stethoscope and globe

17-09-2019 | Rheumatoid arthritis | Highlight | News

Global RA burden ‘significant, yet under-recognized’

Almost 20 million people worldwide were living with rheumatoid arthritis in 2017, with over a million new cases diagnosed each year, according to estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study.

14-08-2018 | Rheumatoid arthritis | Article

Passive smoking in childhood increases the risk of developing rheumatoid arthritis

Seror R et al. Rheumatology (Oxford) 2018: key219. doi: 10.1093/rheumatology/key219

10-07-2018 | Pediatric | Article

Adverse childhood experience and rheumatic diseases

Luiz APL et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4200-5